The race is under way to make faster, cheaper and better GLP-1 drugs that will go beyond reducing obesity levels to treating some of our most difficult conditions| New Scientist
The appointees have "committed to demanding definitive safety and efficacy data", the vaccine sceptic said.| www.bbc.com